INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 137 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $163,000 | +41.7% | 11,100 | +29.1% | 0.03% | +6.7% |
| Q3 2019 | $115,000 | +53.3% | 8,600 | +87.0% | 0.03% | +36.4% |
| Q2 2019 | $75,000 | -31.8% | 4,600 | -30.3% | 0.02% | +46.7% |
| Q1 2019 | $110,000 | +48.6% | 6,600 | +157.6% | 0.02% | +7.1% |
| Q3 2018 | $74,000 | -72.1% | 2,562 | -73.9% | 0.01% | -76.7% |
| Q2 2018 | $265,000 | +452.1% | 9,800 | +292.0% | 0.06% | +445.5% |
| Q4 2017 | $48,000 | -59.0% | 2,500 | -54.5% | 0.01% | -31.2% |
| Q2 2016 | $117,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |